Lymphoma in a patient with systemic lupus erythematosus

Nature Clinical Practice Rheumatology

Volumn 2, Issue 10, 2006, Pages 570-574

  Bernatsky, Sasha ^a   Ramsey Goldman, Rosalind ^b   Lachance, Silvy ^c   Pineau, Christian A ^c   Clarke, Ann E ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; DOXORUBICIN; HEMOGLOBIN; HYDROXYCHLOROQUINE; LA ANTIBODY; LACTATE DEHYDROGENASE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; RO ANTIBODY; SM ANTIBODY; VINDESINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; COMPLEMENT BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CYTOPENIA; DRUG RESPONSE; ELECTROPHORESIS; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; LEUKOCYTE COUNT; LOW DRUG DOSE; LYMPHADENOPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; URINALYSIS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW DISEASES; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LIVER DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOMA, B-CELL; PREDNISOLONE; VINDESINE;

EID: 33749353234     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0295     Document Type: Article

References (20)

1. Gaeta GB et al. (2006) Fever of unknown origin: A systematic review of the literature for 1995-2004. Nucl Med Commun 27: 205-211
2. ter Borg EJ et al. (1990) C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study. J Rheumatol 17: 1642-1648
3. Hind CR et al. (1985) Serum C-reactive protein measurement in the detection of intercurrent infection in Oriental patients with systemic lupus erythematosus. Ann Rheum Dis 44: 260-261
4. Becker GJ et al. (1980) Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 39: 50-52
5. Zein N et al. (1979) Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus. Arthritis Rheum 22: 7-12
6. Williams RC Jr et al. (2005) Studies of serum C-reactive protein in systemic lupus erythematosus. J Rheumatol 32: 454-461
7. Morrow WJ et al. (1981) C-reactive protein in sera from patients with systemic lupus erythematosus. J Rheumatol 8: 599-604
8. Masaki Y and Sugai S (2004) Lymphoproliferative disorders in Sjogren's syndrome. Autoimmun Rev 3: 175-182
9. Bernatsky S et al. (2005) Non-Hodgkin's lymphoma in systemic lupus erythematosus. Ann Rheum Dis 64: 1507-1509
10. Bernatsky S et al. (2005) An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52: 1481-1490
11. Baecklund E et al. (2004) Rheumatoid arthritis and malignant lymphomas. Curr Opin Rheumatol 16: 254-261
12. Bernatsky SR et al. (2006) Cancer screening in patients with systemic lupus erythematosus. J Rheumatol 33: 45-49
13. Bernatsky S et al. (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54: 2550-2557
14. Fisher RI (2003) Overview of non-Hodgkin's lymphoma: Biology, staging, and treatment. Semin Oncol 30 (Suppl 4): 3-9
15. [No authors] (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329: 987-994
16. Rosenwald A et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947
17. Fisher RI et al. (2004) Diffuse aggressive lymphoma Hematology. Am Soc Hematol Educ Program 2004: 221-236
18. Coiffier B et al. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346: 235-242
19. Tan EM et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277
20. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725